Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2297-2302

  Tarragó, David ^a   Aguilar, Lorenzo ^b   García, Raquel ^c   Gimenez, María José ^b   Granizo, Juan José ^d   Fenoll, Asunción ^c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Grana Datos   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOPSY; BLOOD SAMPLING; CEREBROSPINAL FLUID; CHILD; GENETIC VARIABILITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERITONEAL FLUID; PLEURA FLUID; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; SEROTYPE 19A; SPAIN; STREPTOCOCCUS PNEUMONIAE; SYNOVIAL FLUID;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; PENICILLINS; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 79955532103     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01494-10     Document Type: Article

References (29)

1. Aguiar, S. I., et al. 2010. Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J. Clin. Microbiol. 48:101-108.
2. Ardanuy, C., et al. 2009. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J. Antimicrob. Chemother. 64:507-510.
3. Ardanuy, C., et al. 2009. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin. Infect. Dis. 48:57-64.
4. Brueggemann, A. B., et al. 2003. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187:1424-1432.
5. Brueggemann, A. B., R. Pai, D. W. Crook, and B. Beall. 2007. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 3:e168.
6. Choi, E. H., et al. 2008. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 14:275-281.
7. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Dagan, R., N. Givon-Lavi, E. Leibovitz, D. Greenberg, and N. Porat. 2009. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J. Infect. Dis. 199:776-785.
9. Davies, T. A., Y. C. Yee, R. Goldschmidt, D. F. Sahm, and A. T. Evangelista. 2008. Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001. Postgrad. Med. 120(3 Suppl. 1):39-45.
10. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
11. Fenoll, A., et al. 2007. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J. Antimicrob. Chemother. 60:323-327.
12. Fenoll, A., et al. 2009. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J. Clin. Microbiol. 47:1012-1020.
13. Fenoll, A., I. Jado, D. Vicioso, and J. Casal. 1997. Dot blot assay for the serotyping of pneumococci. J. Clin. Microbiol. 35:764-766.
14. Hanage, W. P., et al. 2007. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the postheptavalent conjugate vaccine era. J. Infect. Dis. 195:347-352.
15. Harboe, Z. B., et al. 2010. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin. Infect. Dis. 50:329-337.
16. Mahjoub-Messai, F., et al. 2009. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal vaccination for French children. J. Clin. Microbiol. 47:837-840.
17. Moore, M. R., et al. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197:1016-1027.
18. Muñoz-Almagro, C., et al. 2009. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J. Infect. 59:75-82.
19. Obando, I., et al. 2008. Pediatric parapneumonic empyema, Spain. Emerg. Infect. Dis. 14:1390-1397.
20. Pai, R., M. R. Moore, T. Pilishvili, R. E. Gertz, C. G. Whitney, and B. Beall. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995.
21. Pelton, S. I., et al. 2007. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 26:468-472.
22. Robinson, K. A., et al. 2001. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 285:1729-1735. (Pubitemid 32259907)
23. Sandgren, A., et al. 2004. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J. Infect. Dis. 189:785-796.
24. Shouval, D. S., D. Greenberg, N. Givon-Lavi, N. Porat, and R. Dagan. 2006. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr. Infect. Dis. J. 25:602-607.
25. Singleton, R. J., et al. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792. (Pubitemid 46658647)
26. Sleeman, K. L., et al. 2006. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J. Infect. Dis. 194:682-688.
27. Tarragó, D., et al. 2008. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin. Microbiol. Infect. 14:828-834.
28. Techasaensiri, C., et al. 2010. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr. Infect. Dis. J. 29:294-300.
29. Trzciński, K., C. M. Thompson, and M. Lipsitch. 2004. Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J. Bacteriol. 186:3447-3452. (Pubitemid 38661541)